HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kerins, D. M Articles by Wagner, C. Search for Related Content PubMed PubMed Citation Articles by Kerins, D. M Articles by Wagner, C. Agricola Articles by Kerins, D. M Articles by Wagner, C.

Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine^1,2,3

¹ From the Departments of Biochemistry and Medicine, Vanderbilt University School of Medicine, Nashville, TN, and the Department of Veterans Affairs Medical Center, Nashville, TN.

Background: Although plasma total homocysteine has been identified as an independent risk factor for vascular disease in a multitude of studies, there is a considerable overlap in values between patients at risk and control subjects. The difference in values can be used to distinguish statistically between the 2 groups, provided each group is large enough; however, discriminating between individual patients at risk and control subjects is difficult.

Objective: We investigated whether the precursor of homocysteine, S-adenosylhomocysteine, is a more sensitive indicator of risk.

Design: We measured plasma total homocysteine, S-adenosylhomocysteine, S-adenosylmethionine, creatinine, folate, and vitamin B-12 in 30 patients with proven cardiovascular disease and 29 age- and sex-matched control subjects.

Results: The homocysteine values (±SD) were 12.8 ± 4.9 (95% CI: 11.0, 14.7) µmol/L for patients and 11.0 ± 3.2 (9.8, 12.2) µmol/L for control subjects. The S-adenosylhomocysteine values were 40.0 ± 20.6 (32.3, 47.7) nmol/L for patients and 27.0 ± 6.7 (24.5, 30.0) nmol/L for control subjects (P = 0.0021). The S-adenosylmethionine values were 121.8 ± 42.9 (105.8, 137.8) nmol/L for patients and 103.9 ± 21.8 (95.6, 112.2) nmol/L for control subjects (P = 0.0493). The creatinine values were 110 ± 27 (97, 120) µmol/L for patients and 97 ± 9 (80, 100) µmol/L for control subjects (P = 0.0025). Values for folate and vitamin B-12 did not differ significantly between groups.

Conclusions: Plasma S-adenosylhomocysteine appears to be a much more sensitive indicator of the difference between patients with cardiovascular disease and control subjects than is homocysteine. Both plasma total homocysteine and S-adenosylhomocysteine are significantly correlated with plasma creatinine in patients.

Key Words: Homocysteine • S-adenosylhomocysteine • cardiovascular disease • plasma • S-adenosylmethionine • folate • vitamin B-12

This article has been cited by other articles:

				Y. Yin, T. Zhang, Y. Dai, X. Zheng, L. Pei, and X. Lu Pilot Study of Association of Anembryonic Pregnancy with 55 Elements in the Urine, and Serum Level of Folate, Homocysteine and S-adenosylhomocysteine in Shanxi Province, China J. Am. Coll. Nutr., February 1, 2009; 28(1): 50 - 55. [Abstract] [Full Text] [PDF]

				N. Malanovic, I. Streith, H. Wolinski, G. Rechberger, S. D. Kohlwein, and O. Tehlivets S-Adenosyl-L-homocysteine Hydrolase, Key Enzyme of Methylation Metabolism, Regulates Phosphatidylcholine Synthesis and Triacylglycerol Homeostasis in Yeast: IMPLICATIONS FOR HOMOCYSTEINE AS A RISK FACTOR OF ATHEROSCLEROSIS J. Biol. Chem., August 29, 2008; 283(35): 23989 - 23999. [Abstract] [Full Text] [PDF]

				C. Wagner and M. J. Koury Plasma S-Adenosylhomocysteine Versus Homocysteine as a Marker for Vascular Disease J. Nutr., May 1, 2008; 138(5): 980 - 980. [Full Text] [PDF]

				C. Liu and W. Ling Reply to Drs. Wagner and Koury J. Nutr., May 1, 2008; 138(5): 981 - 981. [Full Text] [PDF]

				C. Liu, Q. Wang, H. Guo, M. Xia, Q. Yuan, Y. Hu, H. Zhu, M. Hou, J. Ma, Z. Tang, et al. Plasma S-Adenosylhomocysteine Is a Better Biomarker of Atherosclerosis Than Homocysteine in Apolipoprotein E-Deficient Mice Fed High Dietary Methionine J. Nutr., February 1, 2008; 138(2): 311 - 315. [Abstract] [Full Text] [PDF]

				C. Wagner and M. J Koury S-Adenosylhomocysteine a better indicator of vascular disease than homocysteine? Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1581 - 1585. [Abstract] [Full Text] [PDF]

				S. P Stabler, R. H Allen, E. T Dolce, and M. A. Johnson Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1422 - 1429. [Abstract] [Full Text] [PDF]

				M. Kohlmeier, K.-A. da Costa, L. M. Fischer, and S. H. Zeisel Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans PNAS, November 1, 2005; 102(44): 16025 - 16030. [Abstract] [Full Text] [PDF]

				H. Gellekink, D. van Oppenraaij-Emmerzaal, A. van Rooij, E. A. Struys, M. den Heijer, and H. J. Blom Stable-Isotope Dilution Liquid Chromatography-Electrospray Injection Tandem Mass Spectrometry Method for Fast, Selective Measurement of S-Adenosylmethionine and S-Adenosylhomocysteine in Plasma Clin. Chem., August 1, 2005; 51(8): 1487 - 1492. [Abstract] [Full Text] [PDF]

				S. R. Davis, E. P. Quinlivan, K. P. Shelnutt, D. R. Maneval, H. Ghandour, A. Capdevila, B. S. Coats, C. Wagner, J. Selhub, L. B. Bailey, et al. The Methylenetetrahydrofolate Reductase 677C->T Polymorphism and Dietary Folate Restriction Affect Plasma One-Carbon Metabolites and Red Blood Cell Folate Concentrations and Distribution in Women J. Nutr., May 1, 2005; 135(5): 1040 - 1044. [Abstract] [Full Text] [PDF]

				A.M.W. Spijkerman, Y.M. Smulders, P.J. Kostense, R.M.A. Henry, A. Becker, T. Teerlink, C. Jakobs, J.M. Dekker, G. Nijpels, R.J. Heine, et al. S-Adenosylmethionine and 5-Methyltetrahydrofolate Are Associated With Endothelial Function After Controlling for Confounding by Homocysteine: The Hoorn Study Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 778 - 784. [Abstract] [Full Text] [PDF]

				I. Baric, K. Fumic, B. Glenn, M. Cuk, A. Schulze, J. D. Finkelstein, S. J. James, V. Mejaski-Bosnjak, L. Pazanin, I. P. Pogribny, et al. S-adenosylhomocysteine hydrolase deficiency in a human: A genetic disorder of methionine metabolism PNAS, March 23, 2004; 101(12): 4234 - 4239. [Abstract] [Full Text] [PDF]

				S. P. Stabler and R. H. Allen Quantification of Serum and Urinary S-Adenosylmethionine and S-Adenosylhomocysteine by Stable-Isotope-Dilution Liquid Chromatography-Mass Spectrometry Clin. Chem., February 1, 2004; 50(2): 365 - 372. [Abstract] [Full Text] [PDF]

				N. P. Riksen, G. A. Rongen, H. J. Blom, F. G.M. Russel, G. H.J. Boers, and P. Smits Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia Cardiovasc Res, August 1, 2003; 59(2): 271 - 276. [Abstract] [Full Text] [PDF]

				R. Carmel, S. Melnyk, and S. J. James Cobalamin deficiency with and without neurologic abnormalities: differences in homocysteine and methionine metabolism Blood, April 15, 2003; 101(8): 3302 - 3308. [Abstract] [Full Text] [PDF]

				S. J. James, S. Melnyk, M. Pogribna, I. P. Pogribny, and M. A. Caudill Elevation in S-Adenosylhomocysteine and DNA Hypomethylation: Potential Epigenetic Mechanism for Homocysteine-Related Pathology J. Nutr., August 1, 2002; 132(8): 2361S - 2366. [Abstract] [Full Text] [PDF]